Catalyst Wire Dossier Catalyst Wire Dossier

Autologous Adipose-Derived Mesenchymal Stromal Cells (AD-MSC) transplantation

· Royan Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Adipose-Derived Mesenchymal Stromal Cells (AD-MSC) transplantation, covering 2017-04-27 to 2017-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Autologous Adipose Derived Mesenchymal Stromal Cells (AD-MSC) Transplantation in Ultra Filtration Failure (UFF) [Phase 1, Phase 2]

See pricing